Lakefront Biotherapeutics NV (0JXZ.IL) Stock Price, News & Chart

	0JXZ.IL	SLS	8SJ.F	688382.SS	NBP	CRVS
Market cap	2.00B	1.85B	1.84B	8.38B	117.16M	889.16M
P/E (TTM)	—	—	—	—	—	—
Forward P/E	—	-91.4	—	-43.8	-0.8	-9.9
Price/book	0.8	13.4	2.4	6.6	0.6	3.9
Dividend yield	—	—	—	—	—	—
1-year change	+10.12%	+464.20%	−37.59%	−48.70%	−75.89%	+35.17%
Today	+2.42%	+3.04%	+1.70%	+4.33%	0.00%	+7.53%

Market cap

2.00B

1.85B

1.84B

8.38B

117.16M

889.16M

P/E (TTM)

—

Forward P/E

—

-91.4

—

-43.8

-0.8

-9.9

Price/book

0.8

13.4

2.4

6.6

0.6

3.9

Dividend yield

—

1-year change

+10.12%

+464.20%

−37.59%

−48.70%

−75.89%

+35.17%

Today

+2.42%

+3.04%

+1.70%

+4.33%

0.00%

+7.53%

Company	Mkt cap	Price	Today
SELLAS Life Sciences Group, Inc.SLS · Biotechnology	1.85B	9.14	+3.04%
Shanghai Junshi Biosciences Co., Ltd.8SJ.F · Biotechnology	1.84B	1.7900	+1.70%
InventisBio Co., Limited688382.SS · Biotechnology	8.38B	14.45	+4.33%
NovaBridge BiosciencesNBP · Biotechnology	117.16M	1.0100	0.00%
Corvus Pharmaceuticals, Inc.CRVS · Biotechnology	889.16M	10.57	+7.53%
Nektar TherapeuticsNKTR · Biotechnology	1.31B	38.48	+1.91%
Coherus Oncology, Inc.CHRS · Biotechnology	131.36M	0.8502	+5.54%
Aclaris Therapeutics, Inc.ACRS · Biotechnology	570.34M	3.6800	−1.60%

Company	Mkt cap	Price	Today
Vir Biotechnology, Inc.VIR · San Francisco, CA	1.99B	11.77	+4.90%
Precigen, Inc.PGEN · Germantown, MD	1.81B	5.06	−3.71%
Mesoblast LimitedMESO · Melbourne, VIC	1.86B	14.29	−3.25%
Braveheart Bio, Inc.BRVE · San Francisco, CA	1.81B	20.11	−6.01%
Shanghai Hile Bio-Technology Co., Ltd.603718.SS · Shanghai, China	1.95B	3.0000	+2.04%
Agios Pharmaceuticals, Inc.AGIO · Cambridge, MA	1.87B	31.38	+0.58%
First Tracks Biotherapeutics, Inc.TRAX · San Diego, CA	2.06B	49.04	+5.83%
Zenas BioPharma, Inc.ZBIO · Waltham, MA	1.85B	28.46	+0.28%

Company	Mkt cap	Price	Today
Vir Biotechnology, Inc.VIR · Biotechnology	1.99B	11.77	+4.90%
BioCryst Pharmaceuticals, Inc.BO1.F · Drug Manufacturers - Specialty & Generic	1.85B	7.25	−1.84%
BioLife Solutions IncBLFS · Medical Instruments & Supplies	1.89B	38.61	0.00%
Xeris Biopharma Holdings, Inc.XERS · Drug Manufacturers - Specialty & Generic	1.91B	10.46	+1.06%
Precigen, Inc.PGEN · Biotechnology	1.81B	5.06	−3.71%
Drägerwerk AG & Co. KGaADRW3.DE · Medical Devices	1.99B	106.00	−0.56%
Mesoblast LimitedMESO · Biotechnology	1.86B	14.29	−3.25%
Braveheart Bio, Inc.BRVE · Biotechnology	1.81B	20.11	−6.01%

Company	Mkt cap	Price	Today
Anheuser-Busch InBev SA/NVBUD · Leuven, Belgium	164.76B	83.67	+3.11%
UCB SAUNC.F · Brussels, Belgium	54.28B	284.70	+3.11%
KBC Group NVKDB.F · Brussels, Belgium	47.47B	117.75	−0.30%
ageas SA/NVFO4N.F · Brussels, Belgium	16.37B	78.25	+0.58%
Elia Group SA/NVE4S.F · Brussels, Belgium	14.18B	129.90	+2.20%
Lotus Bakeries NVLOTB.BR · Lembeke, Belgium	11.37B	13,980.00	−0.14%
Groupe Bruxelles Lambert SA0IN2.IL · Brussels, Belgium	10.53B	79.00	−0.13%
Financière de Tubize SAFTD.F · Brussels, Belgium	10.23B	229.80	+1.68%

Company	Mkt cap	Price	Today
Genexine, Inc.095700.KQ · life sciences	94.14B	2,070.00	+0.73%
Innovent Biologics, Inc.1801.HK · life sciences	154.42B	88.550	+4.12%
SK Biopharmaceuticals Co., Ltd.326030.KS · life sciences	7.10T	90,600.00	+12.27%
WuXi Biologics (Cayman) Inc.2269.HK · life sciences	200.38B	48.680	+0.75%
Evonile Pharma LimitedNOVARTIND.BO · life sciences	42.46B	1,719.85	+0.09%
RPG Life Sciences LimitedRPGLIFE.NS · life sciences	42.93B	2,595.70	−0.11%
Yuyu Pharma, Inc.000220.KS · life sciences	58.66B	3,725.00	+0.40%
KYORIN Pharmaceutical Co., Ltd.4569.T · life sciences	66.01B	1,149.00	+4.64%

Company	Mkt cap	Price	Today
Swedish Orphan Biovitrum AB (publ)0MTD.IL · Correlation 0.32	178.69B	493.90	+2.36%

Company	Mkt cap	Price	Today
ORION OYJ ORION B ORD SHS0M2O.IL	14.35B	101.80	+1.04%
HANSA MEDICAL AB HANSA MEDICAL0RC7.IL	58.79M	41.36	+4.82%
RECORDATI INDUSTRIA CHIMICA E F0KBS.IL	11.01B	53.00	0.00%
VIRBAC SA STE VIRBAC ORD SHS0NM7.IL	3.10B	363.50	+1.25%
SWEDISH ORPHAN BIOVITRUM AB (PU0MTD.IL	178.69B	493.90	+2.36%

Quantisnow·20h ago

LKFT: SEC Form 6-K filed by Lakefront Biotherapeutics

Lakefront furnished a Nov 2, 2026 press release as Exhibit 99.1; the 6-K body itself contains no financial or deal details. Plus members following LKFT got this by push and email at 16:35:57 ET - 2.1s after publication. Lakefront…

LKFT YRD

Quantisnow·20h agoPositive

Lakefront Biotherapeutics Announces Poster Presentation at the 2026 American Society of Hematology Meeting

Plus members following LKFT got this by push and email at 09:01:00 ET - 0.5s after publication. Written by Quantisnow AI from this release. Not financial advice. The poster is scheduled for December 13, 2026, from 7:00 to 9:00 PM ET at the…

Quantisnow·20h agoPositive

Lakefront Biotherapeutics Welcomes Dr. Mehdi Shahidi to its Board of Directors

Plus members following LKFT got this by push and email at 16:01:03 ET - 3.4s after publication. Written by Quantisnow AI from this release. Not financial advice. Dr. Mehdi Shahidi joins as a Non-Executive Independent Director, effective…

LKFT BMY NVS SNY

markets.businessinsider.com·Oct 27

Analysts Have Conflicting Sentiments on These Healthcare Companies: Lakefront Biotherapeutics (LKFT), Prime Medicine, Inc. (PRME) and Electrocore (ECOR)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Lakefront Biotherapeutics (LKFT), Prime Medicine, Inc. (PRME) and Electrocore (ECOR). Morgan Stanley analyst Judah Frommer maintained a Hold rating on…

LLY BMY NAMS

Defense World·Oct 25Negative

Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) Stock Now Rated “Hold” by Wall Street Brokerages

Posted by Defense World Staff on Oct 25th, 2026 View Our Latest Stock Analysis on Lakefront Biotherapeutics American Depositary Shares LKFT stock opened at $31.65 on Friday. The company has a market capitalization of $2.09 billion, a PE…

LKFT LBRX LTGO BCS

Defense World·Oct 25Positive

Critical Analysis: Protagonist Therapeutics (NASDAQ:PTGX) & Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT)

Posted by Defense World Staff on Oct 25th, 2026 Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT – Get Free Report) and Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) are both mid-cap healthcare companies, but…

JNJ LLY VRTX MRK

Stock Titan·Oct 20Positive

Lakefront Biotherapeutics buys back €2.85M in shares

Lakefront held 1,985,157 of its own ordinary shares as of October 16, 2026, after completing the repurchase program. Lakefront Biotherapeutics NV repurchased 107,804 shares between October 12 and October 16, 2026, for a total of…

LKFT

The Globe and Mail·Oct 10·2 outlets

Lakefront Biotherapeutics Discloses Bank of America Stake Cut Below 10% Threshold

Lakefront Biotherapeutics ( (LKFT) ) has issued an announcement. On October 8, 2026, Lakefront Biotherapeutics reported that it had received a transparency notification under Belgian disclosure rules from Bank of America Corporation. The…

LKFT LBRX

Lakefront Biotherapeutics Autoimmune Disorder Pemphigus Treatment Gets FDA Orphan Drug Designation

Published on 08/24/2026 at 04:43 pm EDT - Modified on 08/24/2026 at 04:44 pm EDT A Lakefront Biotherapeutics treatment for the autoimmune disorder pemphigus received orphan drug designation from the Food and Drug Administration. The…

LLY NVS BIIB

MarketScreener·Oct 8Positive

Tranche Update on Lakefront Biotherapeutics NV's Equity Buyback Plan announced on June 9, 2026.

From June 9, 2026 to August 26, 2026, the company has repurchased 916,057 shares, representing 1.39% for ?22.9 million. With this, the company has completed the repurchase of 916,057 shares,... Published on 08/12/2026 at 07:58 am EDT -…

FNF

Days on the list

30 d

1 yr

Best

Trending

—

Install

Lakefront Biotherapeutics NV

Key statistics

Against its peers

Latest news